Contract Research & Services
Contract Services

Contract Services White Papers

View white papers from other Pharmaceutical sectors:
1-15 of 75 results
Is Fear of Risk Your Biggest Risk?
| By NSF International
In this white paper, NSF International's Martin Lush gives his insights into the pharmaceutical industry's relationship with risk. It includes five steps to help you become risk smart.
Contract Research & Services > Contract Services > White Papers
Risk Assessment: A Closer Look
| By NSF International
NSF International’s Andy Barnett takes a deeper look into ICH Q9, Quality Risk Management, with particular focus on the failure mode and effects analysis tool for risk management.
Contract Research & Services > Contract Services > White Papers
Aging Facilities
| By NSF International
Aging facilities is a trendy catchphrase that has taken hold in the biopharmaceutical industry. This white paper by NSF International’s Nicholas Markel provides a few questions to determine if you have an aging facility as well as how to address any issues you may have.
Contract Research & Services > Contract Services > White Papers
NSF: Global Selection Considerations for CMO When Conducting Due Diligence
| By NSF International
Deciding to use a CMO requires a thorough due diligence exercise conducted both as desktop and on-site reviews. This NSF white paper by Maxine Fritz provides the fundamental factors to consider when engaging and deciding on a CMO.
Contract Research & Services > Contract Services > White Papers
NSF: Time To Move Beyond Mediocre CAPAs and Make Them More Effective
| By NSF International
Have you ever wondered why some of your CAPAs fail to achieve the desired improvement? Wouldn’t it be nice if there were a way to evaluate the CAPA before you implement it? NSF proposes the use of our CAPA hierarchy, which will help investigators select a CAPA that is most likely to deliver the desired outcome. Read the white paper for more information on the hierarchy and find out how else to use it.
Contract Research & Services > Contract Services > White Papers
Do you have a robust and compliant CAPA System?
| By NSF International
Pharma biotech companies around the globe are struggling to juggle numerous priorities and challenges. One of their biggest struggles is to effectively manage CAPAs.
Contract Research & Services > Contract Services > White Papers
How to write to Regulatory Agencies when things go wrong
| By NSF International
Your essential guidance on what to do next after you receive a less than positive regulator's audit report.
Contract Research & Services > Contract Services > White Papers
Vetter Development Service Chicago
| By Vetter Pharma International
Our premium manufacturing and clinical supply site near Chicago, Illinois, has the people, processes, and technology to serve pharma and biotech companies of every size with customizable solutions for drug compounds in any stage from Preclinical Testing to Phase II and beyond.
Contract Research & Services > Contract Services > White Papers
Vetter-Ject® Syringe Closure System
| By Vetter Pharma International
Today’s complex, sensitive biologic compounds demand new, innovative delivery systems. The Vetter-Ject® closure system allows you to offer the convenience of a syringe in a design that addresses the unique requirements of highly sensitive compounds.
Contract Research & Services > Contract Services > White Papers
NSF asks why Annex 1 is Important to you
| By NSF International
This white paper details the key reasons for the revision to EudraLex Volume 4, Annex 1: Manufacture of Sterile Medicinal Products. It outlines what you should be asking yourself regardless of the dosage form you are responsible for. It also includes a simple tool to assess the impact on your organization when there is a regulatory change.
Contract Research & Services > Contract Services > White Papers
1-15 of 75 results